$LFVN
Lifevantage Corp

2018 Q3 Form 10-Q Financial Statement

#000084914619000081 Filed on October 30, 2019

View on sec.gov

Income Statement

Concept 2018 Q3
Revenue $55.61M
YoY Change 13.19%
Cost Of Revenue $9.199M
YoY Change 5.26%
Gross Profit $46.41M
YoY Change 14.91%
Gross Profit Margin 83.46%
Selling, General & Admin $17.30M
YoY Change 11.04%
% of Gross Profit 37.28%
Research & Development $400.0K
YoY Change 33.33%
% of Gross Profit 0.86%
Depreciation & Amortization $441.0K
YoY Change 26.0%
% of Gross Profit 0.95%
Operating Expenses $45.09M
YoY Change 15.63%
Operating Profit $1.324M
YoY Change -5.29%
Interest Expense $110.0K
YoY Change -32.1%
% of Operating Profit 8.31%
Other Income/Expense, Net -$159.0K
YoY Change 13.57%
Pretax Income $1.165M
YoY Change -7.39%
Income Tax $300.0K
% Of Pretax Income 25.75%
Net Earnings $911.0K
YoY Change 11.51%
Net Earnings / Revenue 1.64%
Basic Earnings Per Share $0.07
Diluted Earnings Per Share $0.06
COMMON SHARES
Basic Shares Outstanding 13.99M shares
Diluted Shares Outstanding 15.14M shares

Balance Sheet

Concept 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $17.12M
YoY Change 39.3%
Cash & Equivalents $17.12M
Short-Term Investments
Other Short-Term Assets $6.400M
YoY Change 50.59%
Inventory $13.28M
Prepaid Expenses
Receivables $2.367M
Other Receivables $1.360M
Total Short-Term Assets $40.53M
YoY Change 19.09%
LONG-TERM ASSETS
Property, Plant & Equipment $6.063M
YoY Change 51.95%
Goodwill
YoY Change
Intangibles $1.082M
YoY Change -10.87%
Long-Term Investments
YoY Change
Other Assets $1.222M
YoY Change -9.14%
Total Long-Term Assets $11.39M
YoY Change 5.86%
TOTAL ASSETS
Total Short-Term Assets $40.53M
Total Long-Term Assets $11.39M
Total Assets $51.92M
YoY Change 15.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.930M
YoY Change 24.6%
Accrued Expenses $17.65M
YoY Change 5.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $2.000M
YoY Change 0.0%
Total Short-Term Liabilities $23.59M
YoY Change 6.59%
LONG-TERM LIABILITIES
Long-Term Debt $2.921M
YoY Change -40.97%
Other Long-Term Liabilities $1.876M
YoY Change -3.25%
Total Long-Term Liabilities $4.797M
YoY Change -30.35%
TOTAL LIABILITIES
Total Short-Term Liabilities $23.59M
Total Long-Term Liabilities $4.797M
Total Liabilities $28.39M
YoY Change -2.17%
SHAREHOLDERS EQUITY
Retained Earnings -$101.8M
YoY Change -4.1%
Common Stock $125.5M
YoY Change 2.82%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $21.94M
YoY Change
Total Liabilities & Shareholders Equity $51.92M
YoY Change 15.91%

Cashflow Statement

Concept 2018 Q3
OPERATING ACTIVITIES
Net Income $911.0K
YoY Change 11.51%
Depreciation, Depletion And Amortization $441.0K
YoY Change 26.0%
Cash From Operating Activities $2.366M
YoY Change -5.47%
INVESTING ACTIVITIES
Capital Expenditures $86.00K
YoY Change -92.69%
Acquisitions
YoY Change
Other Investing Activities -$1.400M
YoY Change
Cash From Investing Activities -$1.486M
YoY Change 26.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $500.0K
YoY Change 0.0%
Cash From Financing Activities -$328.0K
YoY Change -34.4%
NET CHANGE
Cash From Operating Activities $2.366M
Cash From Investing Activities -$1.486M
Cash From Financing Activities -$328.0K
Net Change In Cash $552.0K
YoY Change -33.25%
FREE CASH FLOW
Cash From Operating Activities $2.366M
Capital Expenditures $86.00K
Free Cash Flow $2.280M
YoY Change 71.82%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2019Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2019Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000 shares
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000 shares
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000 shares
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14034000 shares
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14114000 shares
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14034000 shares
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14114000 shares
CY2018Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
CY2019Q3 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P3Y
CY2019Q3 dei Document Period End Date
DocumentPeriodEndDate
2019-09-30
CY2019Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000 shares
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000 shares
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14034000 shares
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14114000 shares
CY2019Q3 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
-662000 USD
CY2018Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q3 lfvn Notes Receivable Related Party Maximum Commitment
NotesReceivableRelatedPartyMaximumCommitment
2000000.0 USD
CY2019Q3 lfvn Notes Receivable Related Party Interest Rate
NotesReceivableRelatedPartyInterestRate
0.08
CY2019Q3 us-gaap Notes Receivable Related Parties Current
NotesReceivableRelatedPartiesCurrent
2200000 USD
CY2019Q3 lfvn Money Back Guarantee Period
MoneyBackGuaranteePeriod
P30D
CY2019Q3 lfvn Revenue Recognition Sale Returns Acceptable Percentage From Terminated Distributors
RevenueRecognitionSaleReturnsAcceptablePercentageFromTerminatedDistributors
0.30
CY2019Q3 lfvn Percent Of Restocking Fee
PercentOfRestockingFee
0.10
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
700000 USD
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
300000 USD
CY2019Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1400000 USD
CY2019Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1400000 USD

Files In Submission

Name View Source Status
0000849146-19-000081-index-headers.html Edgar Link pending
0000849146-19-000081-index.html Edgar Link pending
0000849146-19-000081.txt Edgar Link pending
0000849146-19-000081-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
lfvn-20190930.htm Edgar Link pending
lfvn-20190930.xsd Edgar Link pending
lfvn-20190930_cal.xml Edgar Link unprocessable
lfvn-20190930_def.xml Edgar Link unprocessable
lfvn-20190930_htm.xml Edgar Link completed
lfvn-20190930_lab.xml Edgar Link unprocessable
lfvn-20190930_pre.xml Edgar Link unprocessable
lfvn093019ex311.htm Edgar Link pending
lfvn093019ex312.htm Edgar Link pending
lfvn093019ex321.htm Edgar Link pending
lfvn093019ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending